<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://www.crsguidelines.org/index.php?action=history&amp;feed=atom&amp;title=ALBUTEROL_%28PROVENTIL%2C_VENTOLIN%29</id>
	<title>ALBUTEROL (PROVENTIL, VENTOLIN) - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.crsguidelines.org/index.php?action=history&amp;feed=atom&amp;title=ALBUTEROL_%28PROVENTIL%2C_VENTOLIN%29"/>
	<link rel="alternate" type="text/html" href="https://www.crsguidelines.org/index.php?title=ALBUTEROL_(PROVENTIL,_VENTOLIN)&amp;action=history"/>
	<updated>2026-04-20T16:49:44Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.37.2</generator>
	<entry>
		<id>https://www.crsguidelines.org/index.php?title=ALBUTEROL_(PROVENTIL,_VENTOLIN)&amp;diff=103&amp;oldid=prev</id>
		<title>Cgabryszek: Created page with &quot;&#039;&#039;&#039;Class&#039;&#039;&#039;  Sympathomimetic (B&lt;sub&gt;2&lt;/sub&gt;Selective)  &#039;&#039;&#039;Pharmacology and Actions&#039;&#039;&#039;  # Has selective beta-adrenergic stimulating properties resulting in potent bronchodilation. # Rapid onset of action (under 5 minutes), and duration of action between 2 - 6 hours.  &#039;&#039;&#039;Indications&#039;&#039;&#039;  # For relief of bronchospasm in patients with obstructive airway disease (asthma, emphysema, COPD) or allergic reactions.  &#039;&#039;&#039;Contraindications&#039;&#039;&#039;  # Symptomatic tachycardia # Known hyperse...&quot;</title>
		<link rel="alternate" type="text/html" href="https://www.crsguidelines.org/index.php?title=ALBUTEROL_(PROVENTIL,_VENTOLIN)&amp;diff=103&amp;oldid=prev"/>
		<updated>2022-04-04T03:16:53Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;&amp;#039;&amp;#039;&amp;#039;Class&amp;#039;&amp;#039;&amp;#039;  Sympathomimetic (B&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;Selective)  &amp;#039;&amp;#039;&amp;#039;Pharmacology and Actions&amp;#039;&amp;#039;&amp;#039;  # Has selective beta-adrenergic stimulating properties resulting in potent bronchodilation. # Rapid onset of action (under 5 minutes), and duration of action between 2 - 6 hours.  &amp;#039;&amp;#039;&amp;#039;Indications&amp;#039;&amp;#039;&amp;#039;  # For relief of bronchospasm in patients with obstructive airway disease (asthma, emphysema, COPD) or allergic reactions.  &amp;#039;&amp;#039;&amp;#039;Contraindications&amp;#039;&amp;#039;&amp;#039;  # Symptomatic tachycardia # Known hyperse...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Class&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
Sympathomimetic (B&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;Selective)&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Pharmacology and Actions&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Has selective beta-adrenergic stimulating properties resulting in potent bronchodilation.&lt;br /&gt;
# Rapid onset of action (under 5 minutes), and duration of action between 2 - 6 hours.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Indications&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# For relief of bronchospasm in patients with obstructive airway disease (asthma, emphysema, COPD) or allergic reactions.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Contraindications&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Symptomatic tachycardia&lt;br /&gt;
# Known hypersensitivity to drug&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Precautions&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Albuterol sulfate has sympathomimetic effects. Use with caution in patients with known coronary disease. Monitor pulse, blood pressure, and cardiac monitor, in CAD patients.&lt;br /&gt;
# When inhaled, albuterol sulfate can result in paradoxical bronchospasm, which can be life threatening. If this occurs, the preparation should be discontinued immediately.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Administration&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# For nebulizer use only&lt;br /&gt;
## For adults and children: place 2.5 mg/3mL albuterol into an oxygen­-powered nebulizer and run at 6-8 LPM. Deliver as much of the mist as possible by nebulizer over 5-15 minutes.&lt;br /&gt;
## Endotracheally intubated patients may be given albuterol sulfate by attaching the nebulizer in-line.&lt;br /&gt;
## Patients placed on CPAP may be given albuterol sulfate by attaching the nebulizer in-line.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Side Effects and Special Notes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Monitor blood pressure and heart rate closely and contact medical control if any concerns arise.&lt;br /&gt;
# Medications such as MAO inhibitors and tricyclics may potentiate tachycardia and hypertension.&lt;/div&gt;</summary>
		<author><name>Cgabryszek</name></author>
	</entry>
</feed>